These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3429376)

  • 21. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis.
    Tebas P; Martinez Ruiz R; Roman F; Mendaza P; Rodriguez Diaz JC; Daza R; de Letona JM
    J Infect Dis; 1991 Jan; 163(1):204-5. PubMed ID: 1984473
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Chambers HF
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():117-22. PubMed ID: 1399943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
    Rouse MS; Wilcox RM; Henry NK; Steckelberg JM; Wilson WR
    Antimicrob Agents Chemother; 1990 Feb; 34(2):273-6. PubMed ID: 2327776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
    Chandrasekar PH; Levine DP; Price S; Rybak MJ
    J Antimicrob Chemother; 1988 Apr; 21(4):461-9. PubMed ID: 3378959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Olay T; Vicente MV; Rodríguez A
    J Chemother; 1989 Jul; 1(4 Suppl):391-2. PubMed ID: 16312454
    [No Abstract]   [Full Text] [Related]  

  • 28. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
    Woods CW; Cheng AC; Fowler VG; Moorefield M; Frederick J; Sakoulas G; Meka VG; Tenover FC; Zwadyk P; Wilson KH
    Clin Infect Dis; 2004 Apr; 38(8):1188-91. PubMed ID: 15095227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
    Sande MA; Brooks-Fournier RA; Gerberding JL
    Am J Med; 1987 Apr; 82(4A):63-6. PubMed ID: 3578331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis.
    Dhawan VK; Yeaman MR; Bayer AS
    J Infect Dis; 1999 Nov; 180(5):1561-8. PubMed ID: 10515816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Maserati R; Cagni AE; Segú C
    Chemotherapy; 1996; 42(2):133-9. PubMed ID: 8697888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Dailey CF; Dileto-Fang CL; Buchanan LV; Oramas-Shirey MP; Batts DH; Ford CW; Gibson JK
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
    Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effectiveness of various antibiotics in the treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis.
    Apellaniz G; Valdés M; Perez R; Martin F; Soria F; Garcia A; Gòmez J; Vicente T
    J Chemother; 1991 Apr; 3(2):91-7. PubMed ID: 1875239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
    Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
    Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
    Kaatz GW; Seo SM; Dorman NJ; Lerner SA
    J Infect Dis; 1990 Jul; 162(1):103-8. PubMed ID: 2141343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
    Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
    Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis.
    Kaatz GW; Seo SM; Aeschlimann JR; Houlihan HH; Mercier RC; Rybak MJ
    Antimicrob Agents Chemother; 1998 Feb; 42(2):254-6. PubMed ID: 9527768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.